GlassScriptPhysician profile
Matthew L Cavey
NPI 1720031263
$22,356.78
in general payments reported to CMS, 2019-2025
22 companies · $9,943 in 2025
The $9,943 reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.12 · 2020: $25.62 · 2021: $324 · 2022: $2,038 · 2023: $2,384 · 2024: $7,580 · 2025: $9,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $6,723 · Consulting Fee: $5,000 · Food and Beverage: $3,743 · Travel and Lodging: $3,440 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $6,723.41 |
| Consulting Fee | $5,000.00 |
| Food and Beverage | $3,743.18 |
| Travel and Lodging | $3,440.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $8,578.39 | 2024-2025 | Bioprotect Balloon Implant System |
| Olympus America INC. | $6,723.41 | 2024 | Rhino-Laryngo Fiberscope |
| Boston Scientific Corporation | $1,489.58 | 2021-2025 | Spaceoar Vue System - 10ml, Spaceoar System, General - Oncology |
| Elekta, INC. | $1,388.13 | 2023 | Elekta Unity, Elekta Medical Linear Accelerator |
| Viewray Technologies INC | $1,346.72 | 2022 | |
| Isoray, INC | $847.34 | 2021-2024 | Brachytherapy Source |
| Accuray Incorporated | $704.79 | 2021-2025 | Tomo Therapy System, Cyberknife System |
| Palette Life Sciences, INC. | $364.02 | 2021-2022 | |
| Gt Medical Technologies, INC | $171.57 | 2025 | Gammatile |
| Theragenics Corporation | $167.44 | 2025 | |
| Blue Earth Diagnostics | $139.24 | 2022-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $69.76 | 2023-2025 | Myrisk, Prolaris |
| Progenics Pharmaceuticals, INC. | $62.57 | 2023-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $52.92 | 2023-2025 | |
| Pfizer INC. | $44.40 | 2023-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Civco Medical Instruments | $41.59 | 2024-2025 | |
| Telix Pharmaceuticals | $40.63 | 2024 | Illuccix |
| Exelixis INC. | $38.48 | 2019 | |
| Zap Surgical Systems, INC. | $25.62 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.64 | 2019 | |
| Medtec LLC | $21.33 | 2024 | |
| Novocure INC. | $15.21 | 2023 | Optune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cavey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.